Haleon (HLN) Change in Receivables (2022 - 2025)

Haleon's (HLN) quarterly Change in Receivables came in at -$198.3 million in Q4 2025, little changed on a QoQ basis from -$197.3 million in Q4 2023.

Haleon (HLN) Change in Receivables (2022 - 2025) Analysis & Trends

Haleon (HLN) has 3 years of Change in Receivables data on file, last reported at -$198.3 million in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Receivables (Qtr)
1	Haleon	43.81 Bn	42.84 Bn	-	-
2	Teva Pharmaceutical Industries	43.29 Bn	39.63 Bn	2.15 Bn	91.00 Mn
3	Zoetis	31.59 Bn	29.91 Bn	1.05 Bn	66.00 Mn
4	Takeda Pharmaceutical	28.67 Bn	22.88 Bn	5.10 Bn	-445.26 Mn
5	United Therapeutics	22.24 Bn	19.58 Bn	683.80 Mn	-1.70 Mn
6	Viatris	18.79 Bn	17.91 Bn	1.46 Bn	126.50 Mn
7	Neurocrine Biosciences	15.71 Bn	15.32 Bn	935.80 Mn	84.30 Mn
8	Elanco Animal Health	12.09 Bn	11.56 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.11 Bn	9.95 Bn	-	-
10	Alkermes	8.19 Bn	7.53 Bn	397.90 Mn	48.85 Mn

Download Data